Skip Nav Destination
Issues
15 June 2011
-
Cover Image
Cover Image
![issue cover]()
TLR4 agonist-formulated GVAX (TEGVAX) significantly increased cytolytic CD8 infiltration into the tumor microenvironment. CT26 tumor-bearing mice were treated with TEGVAX, which resulted in regression of tumor in 40% to 60% of the mice. Tumor-infiltrating CD8 cells (CD8-FITC, CD45-Cy3 conjugates) are shown in yellow and tumor is counterstained with DAPI (40x). For further details, please see Davis and coworkers on page 3984 in this issue.Close Modal - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Highlights
CCR Translations
Molecular Pathways
CCR Focus
Review
Human Cancer Biology
Activated MET Is a Molecular Prognosticator and Potential Therapeutic Target for Malignant Peripheral Nerve Sheath Tumors
Keila E. Torres; Quan-Sheng Zhu; Katelynn Bill; Gonzalo Lopez; Markus P. Ghadimi; Xianbiao Xie; Eric D. Young; Juehui Liu; Theresa Nguyen; Svetlana Bolshakov; Roman Belousov; Suizhau Wang; Guy Lahat; Jun Liu; Belinda Hernandez; Alexander J. Lazar; Dina Lev
Cancer Therapy: Preclinical
Bortezomib Primes Glioblastoma, Including Glioblastoma Stem Cells, for TRAIL by Increasing tBid Stability and Mitochondrial Apoptosis
Thomas Unterkircher; Silvia Cristofanon; Sri Hari Krishna Vellanki; Lisa Nonnenmacher; Georg Karpel-Massler; Christian Rainer Wirtz; Klaus-Michael Debatin; Simone Fulda
Antitumor and Antiangiogenic Activities of BMS-690514, an Inhibitor of Human EGF and VEGF Receptor Kinase Families
Tai W. Wong; Francis Y. Lee; Stuart Emanuel; Craig Fairchild; Joseph Fargnoli; Brian Fink; Ashvinikumar Gavai; Amy Hammell; Benjamin Henley; Christine Hilt; John T. Hunt; Bala Krishnan; Daniel Kukral; Anne Lewin; Harold Malone; Derek Norris; Simone Oppenheimer; Gregory Vite; Chiang Yu
Foretinib (GSK1363089), an Orally Available Multikinase Inhibitor of c-Met and VEGFR-2, Blocks Proliferation, Induces Anoikis, and Impairs Ovarian Cancer Metastasis
Marion Zillhardt; Sun-Mi Park; Iris L. Romero; Kenjiro Sawada; Anthony Montag; Thomas Krausz; S. Diane Yamada; Marcus E. Peter; Ernst Lengyel
Imaging, Diagnosis, Prognosis
Systematic CpG Islands Methylation Profiling of Genes in the Wnt Pathway in Epithelial Ovarian Cancer Identifies Biomarkers of Progression-Free Survival
Wei Dai; Jens M. Teodoridis; Constanze Zeller; Janet Graham; Jenny Hersey; James M. Flanagan; Euan Stronach; David W. Millan; Nadeem Siddiqui; Jim Paul; Robert Brown
Prospective Gene Signature Study Using microRNA to Identify the Tissue of Origin in Patients with Carcinoma of Unknown Primary
Gauri R. Varadhachary; Yael Spector; James L. Abbruzzese; Shai Rosenwald; Huamin Wang; Ranit Aharonov; Heather R. Carlson; Dalia Cohen; Siddharth Karanth; Joanna Macinskas; Renato Lenzi; Ayelet Chajut; Tina B. Edmonston; Martin N. Raber
Cancer Therapy: Clinical
Sirolimus Therapy for Angiomyolipoma in Tuberous Sclerosis and Sporadic Lymphangioleiomyomatosis: A Phase 2 Trial
D. Mark Davies; Petrus J. de Vries; Simon R. Johnson; Deborah L. McCartney; Jane A. Cox; Andreas L. Serra; Peter C. Watson; Christopher J. Howe; Tim Doyle; Kate Pointon; Justin J. Cross; Anne E. Tattersfield; J. Chris Kingswood; Julian R. Sampson
Treatment of Advanced Pancreatic Carcinoma with 90Y-Clivatuzumab Tetraxetan: A Phase I Single-Dose Escalation Trial
Seza A. Gulec; Steven J. Cohen; Kenneth L. Pennington; Lionel S. Zuckier; Ralph J. Hauke; Heather Horne; William A. Wegener; Nick Teoh; David V. Gold; Robert M. Sharkey; David M. Goldenberg
CTLA4 Blockade Induces Frequent Tumor Infiltration by Activated Lymphocytes Regardless of Clinical Responses in Humans
Rong Rong Huang; Jason Jalil; James S. Economou; Bartosz Chmielowski; Richard C. Koya; Stephen Mok; Hooman Sazegar; Elizabeth Seja; Arturo Villanueva; Jesus Gomez-Navarro; John A. Glaspy; Alistair J. Cochran; Antoni Ribas
The Addition of Bevacizumab to Standard Radiation Therapy and Temozolomide Followed by Bevacizumab, Temozolomide, and Irinotecan for Newly Diagnosed Glioblastoma
James J. Vredenburgh; Annick Desjardins; David A. Reardon; Katherine B. Peters; James E. Herndon, II; Jennifer Marcello; John P. Kirkpatrick; John H. Sampson; Leighann Bailey; Stevie Threatt; Allan H. Friedman; Darell D. Bigner; Henry S. Friedman
Predictive Biomarkers and Personalized Medicine
MicroRNAs Are Independent Predictors of Outcome in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP
Alvaro J. Alencar; Raquel Malumbres; Goldi A. Kozloski; Ranjana Advani; Neha Talreja; Shideh Chinichian; Javier Briones; Yasodha Natkunam; Laurie H. Sehn; Randy D. Gascoyne; Rob Tibshirani; Izidore S. Lossos
T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab
Björn Engelbrekt Wahlin; Christer Sundström; Harald Holte; Hans Hagberg; Martin Erlanson; Herman Nilsson-Ehle; Ola Lindén; Marie Nordström; Bjørn Østenstad; Christian H. Geisler; Peter de Nully Brown; Tuula Lehtinen; Martin Maisenhölder; Anne M. Tierens; Birgitta Sander; Birger Christensson; Eva Kimby
A Combined Strategy of SAGE and Quantitative PCR Provides a 13-Gene Signature that Predicts Preoperative Chemoradiotherapy Response and Outcome in Rectal Cancer
Enrique Casado; Victor Moreno García; Jose Javier Sánchez; Montserrat Blanco; Joan Maurel; Jaime Feliu; Carlos Fernández-Martos; Javier de Castro; Beatriz Castelo; Cristóbal Belda-Iniesta; María Sereno; Benito Sánchez-Llamas; Emilio Burgos; Miguel Ángel García-Cabezas; Noemí Manceñido; Rosa Miquel; Damián García-Olmo; Manuel González-Barón; Paloma Cejas
Inhibitor of Differentiation-1 as a Novel Prognostic Factor in NSCLC Patients with Adenocarcinoma Histology and Its Potential Contribution to Therapy Resistance
Mariano Ponz-Sarvisé; Paul A. Nguewa; María J. Pajares; Jackeline Agorreta; María D. Lozano; Miriam Redrado; Ruben Pio; Carmen Behrens; Ignacio I. Wistuba; Carlos E. García-Franco; Jesús García-Foncillas; Luis M. Montuenga; Alfonso Calvo; Ignacio Gil-Bazo
Absence of MMP2 Expression Correlates with Poor Clinical Outcomes in Rectal Cancer, and Is Distinct from MMP1-Related Outcomes in Colon Cancer
John C.T. Wong; Simon K. Chan; David F. Schaeffer; Xavier Sagaert; Howard J. Lim; Hagen Kennecke; David A. Owen; Kwang W. Suh; Young-Bae Kim; Isabella T. Tai
Progesterone Receptor Isoform-Specific Promoter Methylation: Association of PRA Promoter Methylation with Worse Outcome in Breast Cancer Patients
Thushangi N. Pathiraja; Priya B. Shetty; Jaroslav Jelinek; Rong He; Ryan Hartmaier; Astrid L. Margossian; Susan G. Hilsenbeck; Jean-Pierre J. Issa; Steffi Oesterreich
Advertisement
